Enhancing Diabetes Management Approaches for Patients With Uncontrolled Diabetes
Part of paid clinical trials in Madison, Wisconsin.
- Sponsor
- University of Wisconsin, Madison
- Study ID
- NCT05912647
- Status
- Recruiting
Conditions
- Diabetes
- Diabetes Type 2
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 90 Years
- Healthy Volunteers
- Not accepted
Interventions
- MTM — BEHAVIORALParticipants will receive added medicine management support from a pharmacist. This will involve one 60-minute session with the pharmacist either in-person or over the phone and at least four 30-minute follow-up sessions with the pharmacist over the phone.
- CHW — BEHAVIORALParticipants will receive support from a Community Health Worker (CHW) to address life challenges that might be affecting their health and diabetes and to discuss diabetes beliefs and concerns. This will involve one \~30-minute phone call with the CHW to discuss needs and a 2-hour session with the CHW in-person for a comprehensive assessment. Participants will also receive \~10, 15 to 30-minute calls from the CHW to discuss diabetes beliefs and concerns.
Study Details
The purpose of the study is to learn about the best way to enhance pharmacy-related care for diabetes self-management. This research is being done because we want to improve use of medicines and diabetes management among adults with type 2 diabetes and find out which of type of support may improve diabetes self-management for adults. Participants will be assigned to one of 4 groups, and will either: * receive care as usual; or, * receive added medicine management support from a pharmacist; or, * receive support from a Community Health Worker (CHW) to address life challenges; or, * receive both the pharmacist medicine management and the CHW support
Key Dates
- Start date
- Feb 3, 2024
- Status verified
- May 2026
- Primary completion
- Dec 1, 2027
- Completion
- Dec 1, 2027
Study Design
- Enrollment
- 376 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- No Intervention: Usual Care
- Experimental: Medication Therapy Management (MTM)
- Experimental: Community Health Worker (CHW)
- Experimental: MTM + CHW
Primary Outcome Measure
Change in mean hemoglobin A1c score [ Time Frame: Baseline to 6 months ]
Central Contacts
- Martha Maurer608-265-2662
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Wisconsin | Madison | Wisconsin | 53705 |
Find similar trials in Madison, WI
Related Studies
- GLP-1 RA on Liver OMICS in MASLDNot Yet Recruiting · Medical College of Wisconsin · Milwaukee, Wisconsin
- Implementing Artificial Intelligence to Prevent Vision Loss From DiabetesEnrolling By Invitation · University of Wisconsin, Madison · Madison, Wisconsin
- Diabetes and Heart Disease Risk in BlacksRecruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland
- Urinary Vitamin C Loss in Diabetic SubjectsRecruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland